Media OutReach
Appier Drives GenAI-Powered Creatives Transformation with AdCreative.ai, Empowering Hong Kong Brands to Accelerate into the Agentic AI Marketing Era
AdCreative.ai enables brands to generate commercial videos, images, and interactive ad assets quickly and at scale. It also integrates Appier’s seven upgraded AI Agents—Coding Agent, Director Agent, Sales Agent, Campaign Agent, Service Agent, Audience Agent, and Insight Agent, delivering data-driven insights and performance predictions that help marketers achieve scalable, ROI-driven marketing with greater speed, intelligence, and efficiency. The event drew over 100 marketers and advertisers from leading brands and agencies to explore the future of AI-driven marketing.
Recent research underscores the momentum. According to McKinsey, 78% of companies have already deployed AI in at least one business function, with marketing among the top. BCG projects that more than 90% of companies in APAC are planning to scale up GenAI over two years, citing its ability to cut costs and accelerate revenue growth. With its role as an innovation hub, Hong Kong provides fertile ground for brands to experiment, adopt and scale AI solutions.
“Fast-changing consumer markets are placing new demands on Hong Kong brands, particularly in balancing creativity with global expansion,” said Apple Chu, Head of Ad Cloud Sales, Hong Kong, Appier. “High-performing creatives are traditionally costly and time-consuming to produce. AdCreative.ai streamlines this process, delivering diverse formats such as product videos, UGC, and playable ads with compliance checks and performance predictions, becoming a true growth engine for brands.”
“AdCreative.ai’s creative power, combined with Appier’s enterprise Agentic AI solutions’ strengths in data integration, predictive analytics and personalized engagement, is opening a new chapter in data-driven creative marketing,” added Allen Chen, Senior Director of Enterprise Solutions Sales, Greater China, Appier,“ We are enabling Hong Kong brands to understand user behavior, achieve smarter segmentation and activate real-time insights, powering personalized, scalable workflows that improve ROI and keep brands ahead in today’s dynamic market.”
Hong Kong Brands Already Benefiting
Several leading Hong Kong brands have already embraced AdCreative.ai with measurable success:
Future Salad, founded in 2020, is a Hong Kong food-tech company expanding into the overseas market. To address resource limits in producing large volumes of product launch videos to test audience reactions, it adopted AdCreative.ai to overcome filming location restrictions and ensure brand-consistent assets with accurate logo placement. Results exceeded other AI tools: CTR rose 82%, CPC fell 35%, CVR improved 71%, and ROAS surged 143%, making it a key driver of Future Salad’s AI marketing transformation.
Lukfook Jewellery established its first shop in Hong Kong in 1991, marking over thirty years of history. As a brand under Lukfook Group (0590), a listed company on the Main Board of the Hong Kong Stock Exchange, Lukfook Jewellery has earned the trust and admiration of customers through its strong brand reputation, product quality, and commitment to its “Six Heartfelt Services” service standard. AdCreative.ai helps Lukfook preserve jewelry ad aesthetics, cut costly manual workflows, quickly generate diverse creatives, and accelerate AI-enabled e-commerce marketing transformation.
The Korner, founded in 2015, is a Hong Kong footwear brand blending elegance and comfort, with over 20 stores. For its Snoopy collaboration, it used AdCreative.ai to generate commercial videos. Traditional production took 3–4 weeks and heavy resources across social, ad platforms, EDMs, and in-store displays. With AdCreative.ai, videos were produced in hours, personalized to audience preferences, enabling scalable customization, reducing design time, improving ROAS, and doubling video views versus similar campaigns.
As marketing enters a new era, Appier is building on more than a decade of AI expertise to empower brands. Through its AI product suite—Ad Cloud, Personalization Cloud and Data Cloud, Appier delivers Autonomous, Adaptive and Agentic AI solutions that span the entire customer journey, from audience insights and omnichannel marketing to creative generation. Appier remains committed to helping brands turn AI into ROI, equipping Hong Kong enterprises to stay agile and competitive in the Agentic AI era.
Hashtag: #AI #AgenticAI #GenAI #MarTech #AdTech #Appier
https://www.appier.com/en/
https://www.linkedin.com/company/2774891/
https://www.facebook.com/appierinc?locale=zh_TW
Wechat: Appier 沛星互动科技
The issuer is solely responsible for the content of this announcement.
About Appier
Appier (TSE: 4180) is an AI-native SaaS company that empowers businesses to create value through cutting-edge AdTech and MarTech solutions. Founded in 2012 with the vision of “Making AI Easy by Making Software Intelligent,” Appier helps businesses turn AI into ROI through its Ad Cloud, Personalization Cloud, and Data Cloud—each powered by Agentic AI that enables autonomous, adaptive, and real-time decision-making. Today, Appier operates 17 offices across APAC, the US, and EMEA, and is listed on the Tokyo Stock Exchange. Learn more at www.appier.com.
Media OutReach
EtonHouse Rolls Out Enterprise AI Workspace with OpenAI, Aligning Education with Singapore’s National AI Push
The implementation spans the Group’s schools and education brands, including EBridge Pre-School, an Anchor Operator, extending AI integration beyond classroom experimentation into enterprise-wide infrastructure supporting operations, marketing and admissions, finance, human resources, school administration and technology development.
While education was not named among the initial priority sectors identified under Singapore’s national AI strategy, EtonHouse views schools as foundational to building long-term AI capability and literacy across society.
Governance-led AI deployment
The rollout has been structured around enterprise governance principles. Access is managed through role-based access controls, single sign-on authentication and automated provisioning, ensuring that AI tools and information remain aligned to defined job responsibilities and permission boundaries.
ChatGPT Edu operates within a centrally managed internal workspace governed by consistent policies across the Group. External sharing and third-party integrations are enabled only where explicitly approved and aligned with business requirements, reinforcing a secure and compliant AI environment.
This governance-first approach reflects a deliberate shift from isolated experimentation to structured, scalable adoption.
From classroom innovation to enterprise infrastructure
EtonHouse previously developed Lumina, its proprietary AI-powered lesson planning platform. The deployment of ChatGPT Edu represents the next phase of integration, extending advanced artificial intelligence capabilities into enterprise functions.
Within the secure workspace, teams can upload documents for structured analysis, generate comparative reports, conduct scenario modelling and retrieve institutional knowledge more efficiently. Technology teams are also leveraging Codex, OpenAI’s agentic coding tool, to enhance development workflows, supporting code drafting, review and testing while maintaining human oversight and established engineering standards.
The Group is concurrently developing internal AI assistants and structured workflows within defined governance parameters to streamline routine processes and standardise how knowledge is accessed and applied across departments.
Augmentation, not replacement
EtonHouse emphasises that artificial intelligence is being implemented as an augmentation layer rather than a substitute for professional judgement.
“Artificial intelligence is not a shortcut or a replacement technology. It is a learning infrastructure,” said Mr Ng Yi-Xian, Group CEO of EtonHouse International Education Group. “We are developing tools that help students learn more confidently, support teachers to plan and differentiate more effectively, and equip HQ teams to serve schools faster and with higher quality. AI should amplify good practice, not replace it, so we are building the governance and capability to deploy it responsibly at scale.”
The rollout will be supported by structured staff training alongside OpenAI experts clear usage guidelines and ongoing oversight to ensure transparency, responsible usage and alignment with internal policies and regulatory obligations.
“As Singapore advances its national AI ambitions, many institutions are working to bridge the gap between rapidly advancing AI technologies and their ability to deploy them effectively and responsibly. EtonHouse’s rollout of ChatGPT Edu shows how forward-thinking education organisations can translate AI into practical, trusted enterprise-wide systems that empower teams today, while building confidence for the long-term.” added Oliver Jay, Managing Director, International at OpenAI.
Education’s role in Singapore’s AI future
Budget 2026 outlined the formation of a National AI Council to guide coordinated deployment across priority sectors including advanced manufacturing, connectivity, finance and healthcare.
EtonHouse’s implementation reflects how education institutions can apply similar principles of governance, security and enterprise readiness, positioning schools not only as adopters of technology but as contributors to Singapore’s broader AI capability building.
With this move, EtonHouse signals a transition from exploratory AI usage to secure, scalable integration across its global network, reinforcing its commitment to innovation anchored in institutional discipline and responsible deployment.
Hashtag: #ArtificialIntelligence #EnterpriseAI #AIGovernance #AIDeployment #EdTech
https://www.etonhouse.edu.sg/
https://www.linkedin.com/company/etonhouse-international-education-group/
https://twitter.com/EtonHouseGroup
https://web.facebook.com/EtonHouseInternational/
https://www.instagram.com/etonhouseinternational/
The issuer is solely responsible for the content of this announcement.
About EtonHouse International Education Group
- E-Bridge successfully earned multiple accolades for teaching excellence and innovation from the ECDA Awards for Excellence in Early Childhood Development from 2019-2024.
- E-Bridge Pre-School Bukit Panjang clinched the “Outstanding Centre for Teaching and Learning Award” in 2019.
- E-Bridge educators were commended with “Outstanding Early Childhood Teacher Award” in 2021.
- Clinched “Promising Infant Educator Award & Early Childhood Innovation Award” in 2022.
- E-Bridge Pre-School SengKang Square won the “Outstanding Centre for Teaching and Learning Award” in 2023.
- Clinched the “Outstanding Centre for Teaching and Learning Award” for E-Bridge Pre-School Sengkang Square and “Outstanding Early Intervention Professional” in 2024.
- EtonHouse International School Suzhou, an IB K-12 school, garnered recognition as one of China’s top international schools, according to a research firm based in Washington, DC.
- In 2023, EtonHouse China won the ‘Forbes China Best International Education Group Award.’
- In 2024, EtonHouse received the esteemed HoneyKids Singapore Education Awards, achieving Gold for “Best Bilingual Programme”, Silver for “Best Small School in Singapore” and clinched both Gold and Silver for “Principal of the Year (Kindergarten).
- In 2025, EtonHouse launched two news campuses in Saudi Arabia, EtonHouse International Pre-School Granada and EtonHouse International School Granada while achieving 6 HoneyKids Singapore Education Awards in Singapore.
At EtonHouse, collaboration with governments is a cornerstone of its mission. The partnerships include:
- Participation in Singapore’s Anchor Operator (AOP) Scheme, launching E-Bridge Pre-School in 2014 to deliver top-notch infant care and pre-school education for children aged 2 months to 6 years across a network of 31 centres.
- The expansion of EtonHouse’s presence in Suzhou and Nanjing, China came at the invitation of the Jiangsu provincial government, reinforcing its commitment to global education.
- Won an Economic Development Board tender in 2017 and introduced Middleton International School, offering an affordable schooling option for expatriate families.
In 2015, the EtonHouse Community Fund (ECF) was established, dedicated to enhancing the lives of underserved children and youth through education.
The Eton Academy was launched in 2020, providing English, Maths, and Science academic programmes for Nursery 1 to Primary 6 in centres across the island. Building on this success, The Eton Academy expanded in 2025 with the introduction of Elevate After School Care, offering primary school children a holistic, well-rounded after-school experience that complements their academic development.
EtonHouse International Education Group remains unwavering in its commitment to shaping futures and making a meaningful impact on the world through education.
Media OutReach
Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
- UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk
- In a placebo-controlled phase 2 trial in Chinese people with overweight or obesity, UBT251 led to a statistically significant mean weight loss of up to 19.7% after 24 weeks
- UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies.
GUANGDONG, CHINA & BAGSVÆRD, DENMARK – Media OutReach Newswire – 24 February 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G).
UBT251 is being jointly developed by TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology) and Novo Nordisk under an agreement signed in March 2025. United Biotechnology is responsible for development in Chinese mainland, Hong Kong, Macau and Taiwan, while Novo Nordisk is responsible for development in the rest of the world.
The trial, conducted by United Biotechnology, investigated the safety and efficacy of once-weekly injectable 2 mg, 4 mg and 6 mg doses of UBT251 compared to placebo in Chinese people with overweight or obesity. From a baseline mean body weight of 92.2 kg, the highest mean weight loss observed for people treated with UBT251 was 19.7% (-17.5 kg) compared to 2.0% (-1.6kg) in the placebo group after 24 weeks of treatment[i].
Moreover, all dose groups of UBT251 showed statistically significant improvements relative to placebo on key secondary endpoints, including waist circumference, blood glucose, blood pressure and lipids.
In the trial, UBT251 appeared to have a safe and well-tolerated profile. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate and diminished over time, consistent with incretin-based therapies.
“The success of the phase 2 clinical trial of UBT251 in China represents another significant milestone in TUL’s innovation-driven development,” said Mr Tsoi Hoi Shan, Chairman of TUL. “We will continue to focus on chronic diseases, including endocrine and metabolic disorders, accelerate the further development of UBT251, and strive to bring more high-quality treatment options to patients worldwide at the earliest opportunity.”
“We are very encouraged by these data from the trial in China, which demonstrate the potential of UBT251 and its differentiated clinical profile and safety and tolerability profile,” said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk. “We look forward to reporting data from a global trial with UBT251 conducted by Novo Nordisk next year.”
Novo Nordisk recently initiated a global phase 1b/2a trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of different doses of UBT251 for up to 28 weeks in around 330 people living with overweight or obesity. Topline data from that trial is expected in 2027. Novo Nordisk also expects to initiate a phase 2 trial with UBT251 in people with type 2 diabetes in the second half of 2026.
United Biotechnology will present detailed data from the Chinese phase 2 trial at a medical congress later this year. Based on the results of this trial, the company is planning to initiate a phase 3 trial in Chinese patients with overweight or obesity.
About the Chinese phase 2 trial
This randomized, double-blind, placebo-controlled trial enrolled a total of 205 Chinese patients with obesity (BMI ≥ 28.0 kg/m²) or overweight (24.0 kg/m² ≤ BMI < 28.0 kg/m²) with at least one weight-related comorbidity. The baseline mean body weight of the patients was 92.2 kg, with a baseline mean BMI of 33.1 kg/m².
Patients were randomly assigned to receive weekly subcutaneous injections of UBT251 in doses of 2 mg, 4 mg, 6 mg, or placebo for 24 weeks.
The primary endpoint of the trial was the percentage change in body weight from baseline after 24 weeks of treatment.
About UBT251
UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon.
In March 2025, United Biotechnology entered an exclusive license agreement with Novo Nordisk A/S for UBT251. Under the agreement, Novo Nordisk obtained exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture and commercialise UBT251. United Biotechnology retained the rights for UBT251 in Chinese mainland, Hong Kong, Macau and Taiwan.
Hashtag: #UBT251
The issuer is solely responsible for the content of this announcement.
About TUL and United Biotechnology
Founded in 1990, TUL (HKEX: 3933) is mainly engaged in the research and development, production and sales of pharmaceuticals, and ranks among the leading integrated pharmaceutical companies in China. TUL currently boasts seven production bases, covering intermediate products, bulk medicine, finished products, veterinary drugs, empty capsule casings, and medical devices, with the sales networks dotted across nearly 80 countries and regions. United Biotechnology, located in the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, serves as the biopharmaceutical R&D headquarter of TUL. United Biotechnology focuses on the development of high-end biopharmaceuticals to treat major chronic diseases. For more information, please visit www.tul.com.cn.
About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com, YouTube.
Debut at startup-centric zone 4YFN, Dual-presence at World Class Tech Exhibitions in Spain
HONG KONG SAR – Media OutReach Newswire – 24 February 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with Hong Kong Trade Development Council (HKTDC), will lead a delegation of 21 Hong Kong tech companies and institutions to showcase at Mobile World Congress (MWC) 2026—the world’s premier connectivity event, and debut at 4 Years From Now (4YFN) 2026—a global stage for start-ups, taking place concurrently 2-5 March in Barcelona, Spain.
Building on the momentum from MWC 2025—the Delegation will be featuring solutions beyond the Connectivity category, covering focus areas across Devices and Systems, Digital Transformation and support from Ecosystem Partners. The Pavilion duet ought to give a more comprehensive picture of Hong Kong’s innovation and technology (I&T) capabilities in engaging global telecom leaders, enterprise decision-makers, industry partners, and investors, bridging cutting-edge research and development (R&D) into real-world applications and propelling Hong Kong’s I&T sector onto the international stage.
Derek Chim, Head of Startup Ecosystem and Development, HKSTP said, “MWC is a global bellwether for communications technology and tech companies at any stage, to connect with the industry and investors, to have a solid ground that validate solutions, catalyse pilot projects, accelerate commercialisation, and scale internationally.”
Iris Wong, Director, Merchandise Trade and Innovation / Director, External Relations, HKTDC, said, “The Hong Kong Tech Pavilion is an ideal platform for Hong Kong tech enterprises to present their latest R&D achievements at major international tech gatherings, support their journey to explore overseas markets, while highlighting Hong Kong’s strengths as an international innovation and technology hub.”
A series of dialogues and exchanges, spanning from networking reception and themed talks to pitching sessions, will take place throughout the events at the Pavilion to facilitate partnerships and investment opportunities for innovative solutions that are market-ready with high potential for market expansion, in particular, Asmote and Cresento under “Connectivity” make stellar examples of the notion:
- 5G & 6G for Communication, Sensing, and AI computing – Shannon & Turing, (Asmote), located at MWC, specialises in mmWave technology for Integrated Sensing and Communication (ISAC) technology—drone communications and control—rising to the occasion as the city advances its low-altitude economy initiatives, while winning favors for its efficiency in managing industrial scenarios such as smart ports and dark factories. The company previously secured the world’s first 26GHz mmWave 5G commercial communications project, demonstrating its leadership in industrial-grade applications.
- Smart Performance Insights for Sport – Cresento, located at 4YFN, focused on developing an AI-powered shin guard to deliver real-time insights—performance analytics, team leaderboards, and more—with a design that incorporates into gears that athletes already wear and creates minimal friction for, in particular, football players to adapt, will be moving from prototypes to pilot collaborations with European football clubs, academies and sport tech platforms and distributors.
HKSTP continues to join hands with HKTDC to support Hong Kong tech enterprises to “go global” by jointly organising the Hong Kong Tech Pavilion to build bridges linking tech companies with the world. This expedites the industry’s progress in internationalisation to meet the growing demand for I&T globally. This will attract talents, facilitate forward-looking investments and explore opportunities globally, realising the mission of entrepreneurs to reach out to the world and further consolidate Hong Kong’s position as an international I&T hub.
Mobile World Congress Barcelona (MWC) & 4 Years From Now (4YFN)
Date: 2-5 March 2026
Venue: Fira Gran Via, Av. Joan Carles I, 64, 08908 L’Hospitalet de Llobregat, Barcelona, Spain
Hong Kong Tech Pavilion:
MWC – Booth 6E44 at Hall 6
4YFN – Booth 8.1B31 at Hall 8.1
Please visit https://bit.ly/MWC2026HKTech for more information on Hong Kong Tech Pavilion and the exhibitors.
Appendix: Full list of 21 tech entities showcasing at Hong Kong Tech Pavilion during MWC and 4YFN 2026 (in alphabetical order)
| No. | Name of Tech Company / Institution | Category |
| MWC 2026 – Booth 6E44 at Hall 6 | ||
| 1 | Entoptica Limited | Devices & Systems |
| 2 | eSIX | Connectivity |
| 3 | Faraconix Technologies Co., Ltd. | Connectivity |
| 4 | FreightAmigo Services Limited | Digital Transformation |
| 5 | Glassdio Scientific Company Limited | Connectivity |
| 6 | Harvest Elite International Limited | Digital Transformation |
| 7 | HongKong Umedia Limited | Devices & Systems |
| 8 | iASPEC Services Limited | Digital Transformation |
| 9 | InvestHK | Ecosystem Partners |
| 10 | Robocore Technology Limited | Devices & Systems |
| 11 | Shannon & Turing Technology Limited | Connectivity |
| 12 | The Hong Kong Polytechnic University | Ecosystem Partners |
| 13 | Xeroptix Technology | Devices & Systems |
| 4YFN 2026 – Booth 8.1B31 at Hall 8.1 | ||
| 14 | AIGM Limited | Digital Transformation |
| 15 | BWSea Technology (HK) Co., Limited | Digital Transformation |
| 16 | Cresento Limited | Devices & Systems |
| 17 | GoGoChart Technology Limited | Digital Transformation |
| 18 | HairCoSys Limited | Devices & Systems |
| 19 | KNQ Technology Limited | Digital Transformation |
| 20 | Solos Technology Limited | Devices & Systems |
| 21 | Vista Innotech Limited | Devices & Systems |
Hashtag: #HKSTP
The issuer is solely responsible for the content of this announcement.
HKSTP
More information about HKSTP is available at www.hkstp.org
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn